VR Logo

Syngene International Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: Kiran Mazumdar Shaw

Managing Director: Jonathan Hunt

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 21,512.00 Cr

Revenue (TTM): R 2,067.60 Cr

Earnings (TTM): R 354.10 Cr

Cash: R 1,019.90 Cr

Total Debt: R 685.60 Cr

Promoters' ownership: 70.61%

Liquidity: High

52 Week range: R 212.55 - 596.85

Face value: R10.00

Shares outstanding: 40,00,00,000

10 Years Aggregate:

  • CFO: 3,098.70 Cr
  • EBITDA: 3,197.30 Cr
  • Net Profit: 2,084.70 Cr

Stock Performance

Time Period Syngene International S&P BSE Healthcare S&P BSE Mid Cap
YTD70.5344.49-1.03
1 month-7.25-2.180.63
3 months19.9614.378.38
1 Year65.4149.112.57
3 Years29.5911.10-3.29
5 Years24.301.406.06
10 Years--11.675.86
As on 28-Oct-2020
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
201914.86-3.05-3.55
20183.46-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis